John C. Lechleiter

2011

In 2011, John C. Lechleiter earned a total compensation of $16.4M as Chairman, President, and Chief Executive Officer at Lilly Eli & Co, a 1% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$6,530,094
Non-Equity Incentive Plan$2,625,000
Salary$1,500,000
Stock Awards$5,625,000
Other$90,000
Total$16,370,094

Lechleiter received $6.5M of change in pension value and nonqualified deferred compensation earnings, accounting for 40% of the total pay in 2011.

Lechleiter also received $2.6M in non-equity incentive plan, $1.5M in salary, $5.6M in stock awards and $90K in other compensation.

Rankings

In 2011, John C. Lechleiter's compensation ranked 122nd out of 10,747 executives tracked by ExecPay. In other words, Lechleiter earned more than 98.9% of executives.

ClassificationRankingPercentile
All
122
out of 10,747
99th
Division
Manufacturing
40
out of 3,958
99th
Major group
Chemicals And Allied Products
10
out of 1,031
99th
Industry group
Drugs
6
out of 779
99th
Industry
Pharmaceutical Preparations
6
out of 567
99th
Source: SEC filing on March 24, 2014.

Lechleiter's colleagues

We found five more compensation records of executives who worked with John C. Lechleiter at Lilly Eli & Co in 2011.

2011

Bryce Carmine

Lilly Eli & Co

Retired Executive Vice President and President, Lilly Bio-Medicines

2011

Derica Rice

Lilly Eli & Co

Chief Financial Officer

2011

Jan Lundberg

Lilly Eli & Co

Executive Vice President, Science and Technology and President, Lilly Research Laboratories

2011

Robert Armitage

Lilly Eli & Co

General Counsel

2011

Enrique Conterno

Lilly Eli & Co

Senior Vice President and President, Lilly Diabetes

You may also like